UK-based drug maker GlaxoSmithKline (GSK) is in talks with the Indian government for introducing its patented drug, Relenza, which is used for the treatment of Influenza A H1N1 (swine flu).
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/gsk-plans-launch-h1n1-drug-india
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
